Proteomics Market will be growing at a CAGR of 10.4% during the forecast 2018 to 2026

The latest market report published by Acute Market Reports, Inc. “Proteomics Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global proteomics market was valued at US$ 15.1 Bn in 2017 expanding at a CAGR of 10.4% from 2018 to 2026.

Market Insights

Proteomics is a study of a set of a protein called proteomes, produced in an organism or any biological context. Proteomics helps in the evaluation of protein interaction, protein production, metabolic pathways and expression of proteins at subcellular level. Proteomics has found vast applications in drug discovery, clinical diagnostics, and personalized medicine leading to market growth during the past years. Detailed analysis of proteomes provides a better understanding of the development of drugs targeting specific disease pathways efficiently. The discovery of protein biomarkers during disease development and novel drugs for cancer, cardiovascular and neurological diseases have strengthened the proteomics market.

Browse Full Report Originally Published by Acute Market Reports at https://www.acutemarketreports.com/report/proteomics-market

There has been a spurt in the adoption of personalized medicines for various chronic diseases that have resulted in many biotechnology companies and governmental organizations increasing R&D expenditure on proteomics study for the development of effective customized medications. Development of mass spectrometry-based proteomic studies, growing biopharmaceutical companies focus on novel drug discovery auger well for the proteomics market. However, tough regulatory approvals for personalized medicines, scarcity of skilled and qualified research manpower, high cost and long research tenure are some of the challenges faced by the global proteomics market.

In terms of component type, the proteomics market is sub-segmented into instrument type, consumables & reagent type, and services type. Consumables & reagents held the largest share in the global proteomics market in terms of component type owing to high usage of consumables such as kits, strips, and reagents and chemicals for research purposes. Moreover, repeated usage of reagents has augmented the demand for consumables and reagents and projected to continue to grow during the forecast period. Growing research and development studies of novel drugs for various diseases will drive the growth of reagents and consumables market. The usage of novel instrumentation technology such as 2D electrophoresis (2DE) for protein profiling is gripping the market due to its cost-effective nature as the entire protein sample can be studied using the single gel. The 2DE market is projected to grow at a high rate in the instruments sub-segment due to increased demand for this protein in the academic research end-use segment. 

In terms of geography, North America accounted for the largest share in the global proteomics market. The U.S. has been identified as the most lucrative market for proteomics due to the presence of vast diversity in academic research and government-funded research for drug discovery. Moreover, the U.S. is the spearhead in the development of novel drugs for cancer, respiratory diseases, and other chronic diseases. Discovery of protein biomarkers is the result of continuous R&D and government funding in the U.S. Asia Pacific is poised to grow rapidly during the forecast period driven by increased biotechnological research especially in China, Japan, and South Korea, strong government support and socioeconomic growth in the region.

Key Market Movements:

• Growing demand for personalized medicine and strong research & development in proteomics for drug discovery
• Supportive funding by government and growing academic research for proteomic based drug discovery
• Strong growth in the Asia Pacific powered by the rising biotechnology industry and government support
• Development of protein biomarker for chronic diseases to boost proteomics market

List of Companies Covered:

• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Danaher Corporation
• Luminex Corporation
• Perkin Elmer, Inc.
• Waters Corporation
• GE Healthcare
• Bruker Corporation
• Caprion Proteomics Inc.
• Shimadzu Biotech

Market Segmentation:

By Component Type

 • Instrumentation Technology

   o Protein Microarrays

       Biochips

       Microarray Instruments

   o Spectroscopy

   o ELISA

   o X-Ray Crystallography

   o Chromatography

       HPLC

       Ion Chromatography

       Others (Affinity Chromatography & Supercritical Fluid Chromatography)

   o Electrophoresis

   o Others (Surface Plasmon Resonance, Western Blotting, & Protein Fractionation Systems)

 • Consumables and Reagents

   o Protein Microarray Consumables and Reagents

   o Spectroscopy Consumables and Reagents

   o X-Ray Crystallography Consumables and Reagents

   o Chromatography Consumables and Reagents

   o Electrophoresis Consumables and Reagents

   o Immunoassay Consumables and Reagents

   o Protein Fractionation Consumables and Reagents

 • Services

   o Analytical Laboratory Services

   o Data Analysis & Maintenance

   o Quantification Services

 By Application Type

 • Drug Discovery

 • Clinical Diagnostics

By Geography Segment Type

• North America (the U.S., Rest of North America)
• Europe (U.K., Germany, France, Rest of Europe)
• Asia Pacific (China, Japan, India, Rest of Asia Pacific)
• Rest of the World (the Middle East & Africa, Latin America)